Showing Results for
- Academic Journals (19)
Search Results
- 19
Academic Journals
- 19
- 1From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedJoanna Moncrieff, MD, s professor of critical and social psychiatry at University College London and works as a consultant in community psychiatry in London. She has researched and written about theories of drug action,...
- 2From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedThis Special Report contains articles about cannabis use and its potential complications, including cannabis use disorder (CUD). The first piece highlights the use of cannabinoids among the geriatric population....
- 3From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedAlthough vitamin deficiencies and their associated adverse effects are usually considered a public health problem in the developing world, they remain an important clinical consideration for select populations across the...
- 4From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedDr Berlin has been writing a poem about his experience of being a doctor for every month for the past 23 years in Psychiatric Times[TM] in a column called "Poetry of the Times." He is instructor in psychiatry, University...
- 5From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedIt is hard to believe a year has passed since Psychiatric Times[TM] first explored the coronavirus disease 2019 (COVID-19) and potential impacts in March 2020. When the article was written, we thought the virus was...
- 6From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedOn the front cover of the 2020 March issue, Psychiatric Times[TM] featured the story, "The New Game of Microbiology Clue: The Who, When, Where, & Why of the Novel Coronavirus." When Nidal Moukaddam, MD, and Asim Shah,...
- 7From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedA new question must be added to the list that mental health clinicians ask their older patients while taking a history, regardless of age: "Have you used any cannabis products recently?" I learned this lesson during a...
- 8From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedPsilocybin and psilocin are the main psychedelic agents of the psychoactive mushroom genus Psilocybe. (1) Historical and cultural use of these psychoactive mushrooms dates back 3000 years in Mexico and the Southwestern...
- 9From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedTo help in the prevention of the coronavirus disease 2019 (COVID-19), the Food and Drug Administration (FDA) issued an emergency use authorization (EUA) for the Pfizer-BioNTech vaccine on December 11, 2020. One week...
- 10From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedFour recent studies may have turned what we know about attention-deficit/hyperactivity disorder (ADHD) on its head. By following large cohorts from early childhood to adulthood, they claim to have discovered that ADHD...
- 11From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedThe newly minted White House administration wasted no time in enacting its health care agenda, as President Joseph R. Biden Jr signed a flood of executive orders during his first 48 hours in office. Among the top...
- 12From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedDiagnosis and treatment of attention deficit hyperactivity disorder (ADHD) are associated with a variety of practical and clinical challenges. In a recent Psychiatric Times[TM] Viewpoints custom video program, available...
- 13From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedMany patients with bipolar disorder (BD) have comorbid substance use disorders, including nicotine use. Some reports suggest 70% of patients with BD smoke. (1) Importantly, data show that continuing to smoke reduces the...
- 14From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedOn December 11, 2020, the US Food and Drug Administration (FDA) announced it is sued an emergency use authorization (EUA) for the Pfizer-BioNTech coronavirus disease 2019 (COVID-19) vaccine (1); a week later, on December...
- 15From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedLost in the various public policy arguments fueling cannabis decriminalization and legalization laws across the United States is the fact that a percentage of individuals who use cannabis will experience negative...
- 16From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedIndividuals with mental illness continue to struggle with access to treatment in the United States, including in metropolitan hubs. Despite the huge unmet need for additional psychiatrists in the United States, the...
- 17From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedLeading psychiatric organizations have recognized the commitment and exemplary work of Psychiatric Times[TM] Editorial Board members. Jack Weinberg Memorial Award in Geriatric Psychiatry The American Psychiatric...
- 18From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedFirst recognized in 1872 by George Huntington, MD, Huntington disease (HD) is a neurodegenerative disorder that is characterized by progressive decline in motor functioning, cognition, and behaviors. (1) In North...
- 19From:Psychiatric Times (Vol. 38, Issue 3) Peer-ReviewedPresently, there is limited evidence for significant procognitive effects for antipsychotics and other pharmacologic approaches. (1) Therefore, treatment of cognitive impairment in schizophrenia represents a tremendous...